City State Bank Abb Vie Inc. Transaction History

City State Bank

$272 Million
Q3 2024

A detailed history of City State Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, City State Bank holds 9,555 shares of ABBV stock, worth $1.68 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

9,555

Previous 9,678 1.27%

Holding current value

$1.68 Million

Previous $1.66 Million 13.68%

% of portfolio

0.69%

Previous 0.68%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$163.84 - $199.33 $20,152 - $24,517	-123 Reduced 1.27%	9,555 $1.89 Million
Q2 2024 Jul 08, 2024	SELL	$154.79 - $180.76 $48,294 - $56,397	-312 Reduced 3.12%	9,678 $1.66 Million
Q1 2024 Apr 11, 2024	BUY	$159.82 - $182.1 $12,945 - $14,750	81 Added 0.82%	9,990 $1.82 Million
Q4 2023 Jan 10, 2024	BUY	$137.6 - $154.97 $1,651 - $1,859	12 Added 0.12%	9,909 $1.54 Million
Q3 2023 Oct 16, 2023	SELL	$133.59 - $154.65 $380,330 - $440,288	-2,847 Reduced 22.34%	9,897 $1.48 Million
Q2 2023 Jul 10, 2023	SELL	$132.51 - $164.9 $23,454 - $29,187	-177 Reduced 1.37%	12,744 $1.72 Million
Q1 2023 Apr 10, 2023	BUY	$144.61 - $166.54 $347,642 - $400,362	2,404 Added 22.86%	12,921 $2.06 Million
Q4 2022 Jan 11, 2023	BUY	$138.31 - $165.87 $2,074 - $2,488	15 Added 0.14%	10,517 $1.7 Million
Q3 2022 Oct 24, 2022	SELL	$134.21 - $153.93 $10,736 - $12,314	-80 Reduced 0.76%	10,502 $1.41 Million
Q2 2022 Aug 22, 2022	SELL	$137.62 - $174.96 $28,212 - $35,866	-205 Reduced 1.9%	10,582 $1.62 Million
Q1 2022 Jun 01, 2022	BUY	$131.98 - $163.75 $26,395 - $32,750	200 Added 1.89%	10,787 $1.75 Million
Q4 2021 Mar 23, 2022	SELL	$107.43 - $135.93 $21,486 - $27,186	-200 Reduced 1.85%	10,587 $1.43 Million
Q4 2021 Mar 11, 2022	BUY	$107.43 - $135.93 $1.16 Million - $1.47 Million	10,787 New	10,787 $1.62 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $312B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of City State Bank, based on Form 13F filings with the SEC.

News

Stay updated on City State Bank with notifications on news.

Account